Barilà G, Grassi A, Conticello C, Mina R, Marcon C, Fazio F, Cartia CS, Tinelli M, Del Giudice ML, Pilerci S, Belotti A, Pascarella A, Tafuri M, Rocchi S, Mancuso K, Sgherza N, Mele G, Scomazzon E, Gentile M, Porrazzo M, Pescosta N, Furlan A, Febbo MA, Clissa C, Casson A, Ribolla R, Maroccia A, Lisi C, Martino EA, Annibali O, Buda G, Antonioli E, Mangiacavalli S, Tosetto A, Musto P, Gay F, Zamagni E, Petrucci MT, Di Raimondo F, Patriarca F, Zambello R. Lenalidomide maintenance after bortezomib, thalidomide and dexamethasone (VTD) induction and autologous stem cell transplantation: an Italian real-life study of 602 patients. haematol [Internet]. 2025Oct.1 [cited 2025Dec.5];110(10):2481-6. Available from: https://haematologica.org/article/view/12045